Anebulo Pharmaceuticals, Inc. (ANEB) Misses Q2 EPS by 1c

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q2 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $0.

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Morgan Stanley Resumes Tapestry Inc. (TPR) at Overweight
• ArcelorMittal (MT:NA) (MT) PT Raised to EUR65 at Jefferies